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The rise of the nanomaterial metabolite corona,
and emergence of the complete corona
Andrew J. Chetwynd * and Iseult Lynch
Bio–nano interactions are a promising area of research, focused particularly on the interactions between
proteins and nanomaterials (NMs). These interactions lead to the formation of the protein corona, a layer
of proteins adsorbed to the surface of NMs; this corona determines the way in which cells within
organisms “recognise” and interact with NMs. Corona formation has proven critical for cellular uptake,
intracellular localization and toxicity arising from NMs. However, a major class of biological chemicals have
been overlooked in the efforts to understand and predict the interactions of NMs with living organisms,
namely metabolites, which are also involved in signaling cascades and toxic responses in biological
systems. To date, very few studies have investigated this aspect of the NM corona, with initial work
focusing upon the use of carbon nanotubes to clean persistent organic pollutants from contaminated air
or water. As the protein corona field grew, limited interest in the metabolite corona began to emerge with
investigations into the lipid composition of the corona around inhaled NMs and eventually more holistic
analyses of the metabolite corona. We suggest that the metabolite corona co-exists with the protein one,
since these smaller molecules can fit in between proteins, and indeed are often bound into protein
complexes. We hypothesize that metabolites influence NMs impacts on molecular signaling and adverse
outcome pathways. We show initial evidence that the metabolite corona is complementary to protein
coronas, following similar rules of adsorption based on abundance and affinity leading to metabolite
fingerprints akin to protein fingerprints. This work aims to highlight the metabolite corona as an important,
but as yet greatly under represented, area of bio–nano interaction research, and encourage researchers to
explore this aspect of the interactions between NMs and their surrounding biological environments.
1.0 Introduction
The protein corona has been an intense field of research over
the past decade since its potential significance for toxicity,
cellular entry and trafficking were realized. As a result, a wide
range of studies have investigated its formation,1–4 effects on
cellular localization,3,4 toxicological consequences and how
various physico/chemico properties of NMs and biological
matrices can influence its qualitative and quantitative protein
constituents.5,6 The number and breadth of publications in
this field have now enabled models to be constructed to
predict the formation and composition of the corona and the
interactions that the NM–corona complexes have in their
local environs.6 However, one aspect of the corona that has
been largely ignored to date, is the metabolite corona.
Metabolites are orders of magnitude smaller than proteins,
typically below 1000 Da whereas proteins are measured on
the kDa scale, and metabolites are typically reactants,
intermediaries and products of enzymatic activity. While the
idea of interactions between metabolites and NMs is not a
new one, as this is one of the applications of surface
enhanced Raman spectroscopy (SERS)7,8 and several
approaches to “clean” samples prior to analyses,8,9 the
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Environmental significance
The protein corona has been extensively studied over the past decade; the adsorbed proteins confer a biological identity to nanomaterials and influences
their uptake by cells and organisms. However, this protein centric view of the corona overlooks a significant group of molecules in environmental matrices,
namely metabolites, which greatly outnumber proteins. These coronal metabolites are beginning to garner interest from the bio–nano interface
community, although not always discussed in terms of the corona or bio–nano interface. This review encompasses early studies using carbon
nanomaterials for the removal of persistent organic pollutants from water through to metabolomics style analysis of the metabolite corona acquired by
nanomaterials in contact with the model organism Daphnia magna. The co-existence of metabolites and proteins in the corona is also discussed, leading to
the concept of the complete corona.
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potential significance of metabolite constituents of the NM
biomolecule corona in terms of NMs impacts on molecular
signaling pathways and eventual adverse outcome pathways
(AOPs) or targeting ability for nanomedicines has yet to be
systematically explored.
To put the number of metabolites present in just humans
into context it is worth bearing in mind that the latest
genomics studies report 20 678 protein encoding genes,10
while the latest version of the human metabolome database
details >114 000 metabolites.11 These metabolites are
incredibly diverse in terms of structure and molecular
formula compared to proteins which are polymers formed
from a pool of 20 amino acids, or DNA/RNA which are
formed from a pool of just 4 nucleotide monomers.12 While
this doesn't strictly do the complexity of the proteome and
genome justice, because it does not consider post
translational modifications of proteins or acetylation and
methylation patterns of DNA, the range of possible
metabolites is much greater. Metabolites can vary in
molecular weight, polarity and degree of saturation (number
of double or triple bonds) thus providing a wide range of
functions which causes different metabolites to be
concentrated to different extents both within cells and
between different biofluids and tissues.12 For example, highly
polar, conjugatedmetabolites such as testosterone glucuronide
is likely to be found at highest concentrations in urine through
which it is excreted or in the liver where it is produced. Non-
polar hydrophobic metabolites such as phospholipids are
much more likely to be found at high concentrations in cell
membranes and in the lung surfactant, potentially making
them the first metabolites to be encountered by NMs.
Metabolites are several orders of magnitude smaller than
proteins, with the metabolomics community typically
defining a metabolite as a molecule which is required for
metabolic reaction for the growth, function and maintenance
of a cell or organism with a mass <1500 Da.13,14 These
metabolites are vital components of a wide range of cellular
functions such as energy metabolism through glycolysis and
the Krebs cycle in animals or the Calvin cycle in plants, fatty
acid, nucleotide and aromatic amino acid production via the
pentose phosphate pathway15 and steroidogenesis to produce
corticoids, androgen and estrogen steroids from
cholesterol.16 While it is not possible to give an average
concentration of metabolites in biological fluids they will
range from milli/micromolar (carbohydrates, bile acids and
amino acids etc.) to sub-attomolar (steroids,
neurotransmitters etc.).11 As with protein signaling
molecules, metabolites play vital roles in cell signaling; for
example, eicosanoids, which are produced primarily from the
fatty acid arachidonic acid, are a class of oxylipin, which play
important roles in inflammation, pain perception, immune
responses and cell growth, and interact with cell membrane
G-coupled receptors.17,18 Interactions with cellular receptors
are known to be a major mechanism for NM
internalization,19–21 therefore it would not be a surprise to
find that metabolites in the corona may also influence
cellular uptake. Furthermore, many other metabolite
signaling compounds, such as steroids, interact with
receptors of the nuclear receptor class through which they
regulate gene expression.22,23 As such, adsorption of
metabolites and their transport to locations where they do
not normally occur may represent a significant potential
route of toxicity for NMs that is currently unexplored.
This degree of metabolite diversity is conserved between
organisms, as metabolism is a highly conserved process with
only relatively minor differences between species. For
example, whereas 11-ketotestosterone is found at relatively
low levels in mammals, it is the primary androgen in fish.24
When moving to the plantae kingdom, the level of diversity
expands significantly due to the different metabolic pathways
(photosynthesis versus ATP hydrolysis); here the number of
predicted metabolites is an order of magnitude greater than
in humans.25 These encompass metabolites used within the
Calvin cycle for photosynthesis through to flavonoids, which
are phenolic compounds involved in pigmentation, growth,
defense and signaling.26 Furthermore, the rhizosphere, an
area of soil surrounding plant roots is rich in root exudate
and microorganisms known as the root microbiome,
representing another rich source of not just plant metabolites
but also metabolites from this microbiome.27 In addition to
these endogenous metabolites which are produced by, and
play vital roles in, metabolism in organisms, there are many
exogenous metabolites present in the environment,
sometimes referred to as xenometabolites or xenobiotics. Due
to their ubiquity in the environment, xenometabolites may
also bind to NMs, forming part of their acquired eco-corona,
the term used to describe the biomolecular coating acquired
by NMs in the environment.28–30 These can include
molecules such as polyaromatic hydrocarbons,
pharmaceuticals not removed by wastewater treatment plants
or chemicals used in agriculture and their associated
breakdown products or metabolites. Many of these
xenobiotics are known to still be biologically active in the
environment and have been demonstrated to affect
reproductive behavior and neurochemistry of fish to name
just a single organism.30–34 Metabolites have been confirmed
to be present in aquatic organism secretions (e.g., daphnia
conditioned medium),35 while waste water treatment plants
release thousands of tons of human waste including proteins
and metabolites into rivers and oceans around the world.36
There have been a number of proteomics studies of soils37,38
and water columns39 demonstrating that proteins are present
in the wider environment. Given the prevalence of these
chemicals in the environment they are strong contenders to
form part of the eco-corona and thus offer a potential new
route of exposure to a wide range of organisms and plants,
making these interactions key to characterize.
Despite their prevalence in biological organisms and the
environment, the interactions between NMs and metabolites
have yet to be explored extensively by nanoscientists trying to
understand the formation of the corona or the interaction of
NMs with the organisms they become exposed to. It is highly
Environmental Science: NanoCritical review
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likely that the recruitment of the protein corona is influenced
by the presence of metabolites particularly given that many
NMs are produced and purchased in solutions stabilized by
citrate, a metabolite from the citric acid cycle, while others
are stabilized with tannic acid, glutamic acid, oleic acid,
salicylic acid, or trichloroacetic acid.40,41 This also means
that data about metabolite–protein interactions in the corona
has already been collected serendipitously in many studies
but the significance of this information has been overlooked
to date. The reverse is also a distinct possibility as many
proteins are known to interact with both endogenous
metabolites or drugs,42–44 and as such the binding of
proteins onto NMs is likely to attract metabolites also.
Exploring and understanding the role of the metabolites in
the NM bio-/eco-corona is an exciting prospect as many
metabolites, either naturally occurring in organisms such as
amino acids, sugars and lipids or unnatural contaminants
from human activity such as cosmetics, pharmaceuticals and
agricultural waste can act as signaling molecules or
toxicants.31 Thus, understanding the contribution of
metabolites to the NM corona, elucidating the fraction of the
total corona that constitutes metabolites, and potentially
uncovering new metabolite driven mechanisms behind NM
uptake, distribution and toxicity that have, to date, eluded
researchers due to the lack of available information on the
metabolites components of the corona, offers important new
research directions. The various potential mechanisms of
corona formation and interactions between metabolites and
proteins and between the corona and NMs are illustrated
schematically in Fig. 1, and include metabolite recruitment
of other metabolites or proteins, or protein-induced
recruitment of metabolites as has been established for
protein-induced recruitment of other proteins. Although the
evidence for the metabolite corona is quite sparse to date,
there are tantalizing hints that similar patterns of interaction
exist for metabolites as for proteins, including abundance
driven initial binding and differential binding of metabolites
based on their affinities for the NMs surface leading to NM
metabolomic fingerprints, which we highlight in the sections
below where relevant. Thus, we present here a conceptual
framework for the metabolite corona, complementary to and
indeed interwoven with, that of the protein corona. It will
only be once a full understanding of all aspects of the
complete bio-/eco-corona is achieved that the field can hope
to expand into the tightly regulated world of medicine to
deliver on the promise of novel nanomedicines and indeed
novel agrochemicals.
In much the same way that nanoscientists have leveraged
the success of proteomics in the analysis of the protein
corona, researchers will need to embrace metabolomics, a
much younger omics science, to uncover the secrets of the
metabolite corona. Indeed, it will be necessary to bridge both
proteomics and metabolomics in order to begin to unwind
the interactions between metabolites and proteins during the
formation and evolution of the complete NM corona and
interactions of the combined biomolecule corona with living
organisms and the environment. In some cases, this will
require additional instrumentation and expertise, particularly
for researchers coming from the environmental background,
however, researchers already involved in protein corona
characterisation already possess the necessary equipment to
investigate the metabolite corona. As such it may be possible
to assess both in parallel and collect twice as much data from
the same sample, and a workflow for this, including some of
the relevant points to consider is presented, that captures in
brief some of the main challenges and pitfalls to watch out
for. Future instrument optimization may allow for
simultaneous analysis of the complete corona.
This work aims to position the metabolite corona as a new
and greatly underappreciated aspect of the bio–nano
interface, which sits alongside and complements the protein
corona. We introduce the metabolite corona as a key
constituent of the complete corona, by discussing current
research in this emerging field and looking ahead to the
future whereby this aspect of the corona may unlock further
understanding of NM uptake, distribution, toxicity and drug/
agrochemical delivery.45 It is clear from the current research
that there are key similarities between the metabolite corona
Fig. 1 Schematic illustration of hypothetical mechanisms for formation of the complete corona around NMs. A wide range of possibilities exist for
the corona to acquire metabolites and proteins. (a) The direct adsorption of proteins from the environment is the predominant model at the
moment, however protein–protein interactions (b), metabolite adsorption (c), metabolite induced adsorption of proteins (d), protein induced
recruitment of metabolites (e), metabolite induced recruitment of further metabolites (f) or more likely a complex combination of all
aforementioned methods with elements such as metabolite induced conformational changes in proteins (g).
Environmental Science: Nano Critical review
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and protein corona fingerprints, which this review aims to
spotlight. These key properties of the metabolite corona, such
as preferential binding based on surface affinities and
evolution based on available metabolites and competition
from other biomolecules, which shadow those of the protein
corona are highlighted throughout. Key directions in which
to focus future research are identified, including
development of predictive models of the complete corona.
2.0 Targeted analysis of persistent
organic pollutant/xenometabolites
binding to NMs
While not presented as corona formation, the ability of small
molecule pollutants, which are often referred to as
xenometabolites, to interact with NMs has been investigated
for at least 12 years, with initial studies investigating the
sequestering of persistent organic pollutants (POPs) by
carbon nanotubes (CNTs). Due to the potential applications
of carbon NMs in environmental remediation for removal of
POPs, several studies modelling the binding characteristics
of dioxins, polyhalogenated compounds and poly aromatic
hydrocarbons (PAH) have been carried out. It is worth noting
that in real environmental systems larger molecules such as
humic acid would also compete for the NM surface, and
indeed natural organic matter (NOM) is a known sink for
pollutants, such that co-binding of pollutants and humics
could occur.46–49
The first paper to report the adsorption of
xenometabolites to NMs was Long et al. in 2001 (ref. 50) who
found that dioxins exhibited strong π–π interactions between
the hexagonal arrays of atoms in the CNT and the benzene
rings in dioxins. Since then a wide array of POPs have been
found to adsorb to carbon NMs including
polyhalogentaed51–53 and PAH54–56 compounds and that this
adsorption is highly pH dependent,51–53 an important factor
also for protein corona formation. As with the protein
corona, several models have also been developed to
investigate computationally how these POPs interact with
NMs and demonstrated that the adsorption of PAHs
correlated with CNT surface area, micropore volume, volume
ratio between the mesopores versus micropores and planar
versus non-planar structures.55,56 These surface-specific
interactions are analogous to those reported previously for
proteins, where mesoporous silica NMs resulted in different
proteins binding compared to smooth silica NMs, and
differential protein binding to different pore volumes.57
While these investigations were not explicitly focused on
endogenous metabolites they highlight the fact that
xenometabolite adsorption to NMs may play a critical role in
biological and environmental systems. Furthermore, these
studies highlighted the importance of characterizing the
adsorption characteristics of these compounds due to the
potential for increased toxicity to humans and the wider
environment through so-called Trojan horse effects, as seen
in the protein corona, whereby they are carried into
organisms as the NMs are taken up.58–60 Due to the
ubiquitous nature of both POPs and NMs in the natural
environment it is highly likely that these NM–POP complexes
are to be found in all cases where both are present. Thus, a
thorough understanding of the (xeno)metabolite corona and
how it interacts with biological systems is vital to
comprehend the potential harm caused by the release of
NMs into the ecosystem.
3.0 Moving towards understanding
the role of endogenous metabolites
in the metabolite corona
An important application areas for NMs in the 21st century is
their role as nanomedicines. Researchers have already begun
to investigate the potential of the NM protein corona as a tool
to diagnose patients and to understand the distribution and
uptake of nanomedicines and its role in determining the
efficacy of such medications.61–63 While proteins play vital
roles in the signaling pathways determining NM uptake and
biodistribution, metabolites are also important in these
signaling cascades, such as eicosanoids in inflammation, and
in a wide range of metabolic processes. As such,
characterizing the endogenous metabolite corona could
unlock the potential of nanomedicines while also informing
studies into human and ecological NM toxicity.
3.1 Lipid corona
The first class of chemicals to be investigated in terms of the
NM metabolite corona were lipids. The lipid constituents of
the corona are of particular interest as they represent an
initial point of contact between NMs and living organisms in
the form of the lipid bilayer in cell membranes64 or in lung
surfactant for inhaled NMs.65,66 Lung surfactant is comprised
of 90% lipids and just 10% proteins.66,67 While the
abundance of compounds doesn't necessarily reflect the
abundance in the corona, it is important to consider the fact
that in cases of NM inhalation, the predominant class of
molecule present in the lungs are lipids not proteins and that
25% of human NM exposure is via inhalation.68 This makes
the metabolite corona potentially of huge significance in the
lungs particularly if there is evidence that it affects the
uptake of NMs. The lipid portion of lung fluid is comprised
of phospholipids and cholesterol while there are 4
predominant proteins, namely surfactant protein-A (SP-A),
SP-B, SP-C and SP-D. SP-A and SP-D, which are large
hydrophobic proteins that play a role in innate host defense
and bind to inhaled NMs and pathogens.69 SP-B and SP-C are
smaller hydrophilic membrane proteins which reduce
alveolar surface tension.69 These properties and functions of
the protein surfactant are vital, which the metabolite corona
may influence thus affecting alveolar surface tension and NM
uptake by alveolar epithelial cells and macrophages.66
Environmental Science: NanoCritical review
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As with the environmental contaminants discussed above,
several studies of endogenous metabolites were assessed as
smaller well controlled groups of metabolites rather than in
the complex mixtures that NMs are exposed to in reality. In
2012, Ruge et al., investigated the interplay between lung
surfactant lipids and proteins and its effect on macrophage
clearance of NMs.67 Here magnetite nanoparticles (mNPs)
exposed to SP-A and SP-D significantly increased alveolar
macrophage uptake. When exposed to the vesicles
constructed from surfactant lipids in the absence of the
surfactant proteins, creating a lipid corona, cellular binding
of starch coated mNPs greatly increased compared to pristine
mNPs, indicating that lipids in the corona are key for
internalisation. However, phosphatidylcholine-coated mNPs
did not show increased internalization, due to their already
lipid like surface coating. Interestingly surfactant lipids
diminished the effect of SP-A on mNP–macrophage
interactions, potentially due to the role surfactant lipids play
in the stimulation of immune cells; surfactant lipids and SP-
A may also competitively bind to the surface of NMs leading
to this reduced effect, demonstrating the importance of
generating competitive binding data to enable accurate
binding kinetics to be modelled.67 Computational modelling
has also been used to investigate the inhalation route of
exposure to silver and polystyrene NMs.66 Here course-
grained molecular dynamic models determined that the
lipids and proteins of the alveolar fluid immediately coat the
NMs upon exposure. This immediate formation of a complex
lipid–protein corona reflects the rapid formation of the
protein corona, though it remains unclear if the metabolite
corona also evolves over time in the same way the protein
corona does.70 The lipid compositions acquired by 5 and 15
nm AgNPs were highly conserved, and the model showed that
lipids formed a bilayer on the hydrophilic AgNPs but on the
hydrophobic PS-NPs only a monolayer formed. For both
NMs, the presence of surfactant didn't hinder the formation
of the lipid corona. In fact, SP-B and SP-C were found to
mediate the formation of the corona by interacting directly
with the lipids within the corona (as per the model shown
schematically in Fig. 1e). In the Ag-NM corona SP-B
interacted with, and oriented parallel to, the bilayer whereas
the helical fragment of SP-C adopted a transmembrane
conformation. Due to the monolayer on the PS-NPs both SP-B
and C orientated parallel to the lipid monolayer.66 This is a
particularly critical finding as it demonstrates that protein
conformation and/or orientation is highly dependent upon
the presence and structure of lipids in the corona. While
these aspects of the protein corona are currently poorly
understood or studied it does suggest that a deeper
understanding of these metabolite–protein interactions in
the corona may be key for any biological functionality if it
enables or hinders access to aptamers. An important
question for future research is to explore whether lipid-
mediation of surfactant-like protein binding to NMs is a
general phenomenon and whether it applies also to less
lipid-like proteins and to other NM types.
It is well documented in the protein corona literature that
the NM surface chemistry is a significant determining
property in the composition of the protein corona formed
around a NM.71,72 This aspect of the formation of the
metabolite corona has not yet been thoroughly investigated
with just a single study focusing on the impact of NM
composition on metabolite corona composition. Gold NMs
with a core diameter of 14 nm were functionalized with
either cationic or anionic surface modifications. Anionic
modifications were made by coating the AuNPs with citrate
(anionic) whereas two cationic coatings (16-
(mercaptohexadecyl)-trimethylammonium bromide (MTAB) or
polyĲallyamine)hydrochloride (PAC)) were investigated. These
NPs were exposed to 4 different vesicles made up of either
100% dipalmitoylphosphatidylcholine (DOPC), 9 : 1 DOPC :
1,2-dioleoyl-sn-glycero-3-phospho-L-serine (DOPS), 9 : 1 DOPC :
1,2-dioleoyl-sn-glycero-3-phospho-1-rac-glycerol, (DOPG) and 9 :
1 DOPC : 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine
(DOPE) (Fig. 2).64 Previously a study using quartz crystal
microbalance (QCM) measurements showed that DMPC and
DOPC interact with the same gold NPs when exposed to lipid
bilayers.73 Interestingly hydrodynamic size was only
significantly increased for the PAC-AuNPs upon vesicle
exposure suggesting the NMs had agglomerated. The zeta
potential inverted when the AuNPs were introduced into the
9 : 1 DOPC :DOPS and 9 : 1 DOPC :DOPG vesicles, suggesting
that the anionic lipids had interacted with the cationic
AuNPs. However, for the 100% DOPC and 9 : 1 DOPC :DOPE
vesicle exposures no change in zeta potential was observed,
likely due to the zwitterionic nature of DOPC and DOPE
maintaining a positive surface despite lipid binding. When
exposed to DOPC the AuNPs bound 80% of the available
lipids with PAC and MTAB modified NMs retuning very
similar lipid coronas. When co-exposed to DOPS and DOPC
the PAC modified AuNPs bound 95% of both lipids compared
to <65% for the MTAB modified NPs. This suggests that
surface modifications influence corona formation in complex
mixtures and that metabolites may aid the recruitment of
others and vice versa (as suggested in Fig. 1d and f). This co-
recruitment of metabolites (or proteins) is an important
consideration as past exposures are going to have significant
implications in the evolution of the complete corona; co-
adsorption of toxins (xenometabolites) to the corona is
important for potential Trojan horse effects.
The disparity between PAC and MTAB is due to differences
in chemical structures: MTAB contains a quaternary
ammonium head group and is less prone to forming hydrogen
bonds, PAC is comprised of C16 chains more favorable for
hydrophobic interactions with the lipid backbones. This
confirms that surface modification/ligand binding plays a
significant role in the formation of the metabolite corona. The
anionic AuNPs only weakly interacted with the lipids with<5%
adsorbing to the NMs.64 These findings suggest that
manipulation of the NM physico/chemico properties
influences the composition of the metabolite corona in much
the same way it affects the protein corona. It remains to be seen
Environmental Science: Nano Critical review
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how these properties affect interactions between the proteins
and metabolites in the complete corona (see schematic in
Fig. 1). However, it does potentially open the door for “designer”
coronas through manipulation of NM properties with the goal of
targeting specific tissues or having specific functions.
A significant recent publication quantified both the
protein and lipid corona of polystyrene NMs while
highlighting that a full characterization of the complete
corona is likely to be key in future safe clinical applications
of nanomedicines.45 Interestingly, cholesterol levels in the
corona of polystyrene NMs were independent of the surface
area but correlated with particle size. Furthermore, over a 24
h time period cholesterol levels decreased in the corona
potentially due to lipid dissociation. Conversely, triglyceride
concentrations in the corona had a correlation with surface
area of the NMs. As with cholesterol there was a decrease in
the concentration of triglycerides over time, this however was
related to a decrease in apolipoprotein E which has a role in
transporting lipids around the body. The authors noted the
intriguing point that the binding mechanism between
lipoproteins and NMs are not understood and that whether
the lipids were present on the lipoprotein when it bound to
the NM, or whether the lipids were adsorbed to the NM first
which then attracted the lipoprotein, is not yet known.45 This
perfectly highlights the need to characterise the metabolites
within the corona as they have the potential to be key driving
factors in the formation of the complete corona.
3.2 Targeted plasma metabolites
The blood is the most common biological matrix used for
protein corona characterisation, as once within the body it's
likely that NMs will become exposed to blood either after
inhalation, ingestion or topical contact and thereby be
systemically delivered around the body. Blood also represents
one of themost commonly analysed biofluids in bioanalysis for
drug development and biomarker discovery using proteomic
and metabolomic approaches. As such, databases have been
developed detailing the proteomic74,75 and metabolomic76,77
composition of human (and animal e.g. calf, rabbit etc.) blood
making it an ideal candidate for coronal analysis.
A biological surface adsorption index (BSAI) has been
proposed as a method to characterise competitive interactions
between NMs and a selection of (xeno)metabolites. One such
study proposed that the major factors driving adsorption of
(xeno)metabolites to MWCNTs and 12 other NMs were primarily
the lipophilicity of the (xeno)metabolites, their hydrogen bond
basicity and their dipolarity/polarizability. Furthermore, this study
demonstrated a strong binding capacity of 7 steroid hormones,
progesterone, testosterone, estradiol, hydrocortisone, aldosterone,
L-thyroxine and ethinyl estradiol, which play vital roles in
regulating metabolism and act as important signaling molecules
in biological systems, with ethinyl estradiol being the principal
component in the contraceptive pill, an important endocrine
disrupting chemical in the environment.22,78 Furthermore, the
model predicted that DNA bases would also bind to NMs with a
descending order of preference of adenine, thymine, guanine and
cytosine, implying that NMs may interact with DNA, potentially
being a source of mutations. The BSAI model builds upon the
early binding studies of PAHs79 and is the first to model the
binding properties of endogenous metabolites.
The presence of metabolites adsorbed to the surface of
NMs was found to induce protein conformational changes
that facilitated recognition and cellular uptake of the NMs.80
This study provides a critical insight into the significance of
metabolites in the protein corona and leaves the door open
for a host of follow-up work to begin to develop a full
understanding of the roles that both proteins and
metabolites play in the recruitment of each other into the
corona and how they interact to bring about physiological
effects in the body.
3.3 Dietary corona
Although very much an overlooked exposure route, dietary
sources of NMs make up approximately 16% of human
Fig. 2 Investigation of the effect of NM surface functionalization on gold NM interactions with lipids, and isolation of the lipid corona. a) Citrate
capped AuNPs, b) 16-(mercaptohexadecyl)trimethylammonium bromide capped AuNPs, c) polyĲallylamine) hydrochloride capped AuNPs, d) vesicle
phospholipid structures, and e) lipid corona characterisation workflow. Reprinted with permission from Zhang et al. Analytical Chemistry, 2018, 90,
14387, Copyright (2018) American Chemical Society.64
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exposures to NMs, compared to 58% and 25% for topical and
inhalation exposure, respectively.68,81 The high dietary
exposure is typically through silica NMs which are used as a
food additive (E551) and act as an anticaking agent.81
Furthermore, nano silver is being used as an antimicrobial
and in some cases as a (supposed) supplement in health
foods, nano selenium is used as an additive in green tea
products, nano iron is used to treat contaminated water or as
a supplement, and a variety of metal oxides are used as
colorants or may elute from packaging materials.82 Due to
the diverse compositions of diets around the world each meal
or item of food represents a complex mixture of a vast array
of biomolecules such as proteins and metabolites from a
range of plant and animal species, making the dietary-corona
potentially the most complex and diverse corona relevant for
human exposure. Indeed the diversity of the food
metabolome has been reviewed extensively.83–85 Despite the
potential significance of this, just a single study has been
performed thus far investigating interaction of NMs with
dietary saccharides from honey and lipids from olive oil.81
Silica NM exposure to honey revealed a correlation
between exposure time and honey concentration with more
negative zeta potentials, however temperature appeared to
have no effect on zeta potential. When run as mixtures of
pure glucose, fructose, sucrose and maltose the zeta potential
did not vary and the hydrodynamic size actually decreased
suggesting other biomolecules in honey are responsible for
the changes in DLS and for stabilizing the NMs. In honey,
glucose and fructose interacted with the silica NMs in a
concentration dependent manner at 25 °C, however zeta
potential and hydrodynamic diameter were not affected by
time but increased with increasing temperature. Sucrose and
maltose were outcompeted by glucose and fructose (due to
their higher concentration in honey) in the honey and
showed no interaction, however when incubated with the
NMs individually no preference for particular saccharides
was observed.81 Upon exposure to olive oil DLS and zeta
potential measurements were not possible due to the colour
of the oil (which is excessively light scattering) and the fact
that it lacks electrical conductivity. Instead, GC-MS was used
to characterize the adsorption of lipids, which was found to
be minimal and not correlated with temperature or exposure
time. The poor interaction between lipids and the silica NMs
was ascribed to the hydrophilic nature of the silica NMs
generating repulsion between the lipids and silica.81 These
findings highlight the importance of determining binding
affinities for metabolites (as well as for proteins) individually
and under competitive conditions, and assessing the nature
of the binding, in order to facilitate the development of
predictive models of the compete corona (proteins and
metabolites).
The link between NMs taken up by edible plants and
dietary exposure to the NMs has yet to be explored, although
evidence is emerging of bioaccumulation in edible plants.86
The role of the metabolite corona in facilitating NM uptake
into plants, their transformation in situ, and the impact of
NMs on the metabolites themselves are all areas of active
research currently linked to nano-enabled agriculture.
4.0 The application of untargeted
analysis of the NM metabolite corona
Only via a full understanding of the protein and metabolite
corona can their impact be understood and harnessed for
better informed policies regarding NM use, disposal, safe-by-
design NMs, and to exploit their full potential in
nanomedicine. As such, a more holistic approach to
analyzing the complete NM corona is required, with
approaches to characterize and quantify the metabolite
corona following in much the same manner as the protein
corona is currently analyzed. In the case of the metabolite
corona the field of metabolomics has a lot to offer,87 whereby
a global analysis of metabolite (<1500 Da) are analyzed in as
unbiased a fashion as possible.
4.1 Isolation of the metabolite corona
The first issue to arise when analyzing the metabolite corona
is the generation of the sample for analysis following the
incubation of the NMs in the desired matrix. There are two
very different approaches to this: the first is a passive
approach whereby the matrix is characterised prior to NM
exposure and then again once the NMs have been pelleted
(by centrifugation) and removed. Upon the second
characterisation of the matrix following exposure it can be
inferred that any drop in metabolite level is a result of
adsorption to the NM, particularly if suitable controls are run
to demonstrate that the metabolites do not adsorb to the
reaction vessel. This technique will work very well for initial
investigations using known standards for metabolites, either
singly or as mixtures, and also offers the possibility to
properly quantify the adsorption. However, in complex
biological matrices where metabolite concentrations are
dynamic this approach becomes more difficult, though would
still work and drops in metabolite concentrations may still
be detectable, however quantification of all metabolites then
becomes unfeasible. This approach is also of no use in
realistic exposure monitoring conditions as it would be
impossible to analyse the matrix before and after exposure.
The second, more direct, approach is to elute the metabolites
from the NMs, as is done for protein corona analysis.35,88
There are a number of possible ways to do this, many of
which have been applied in the metabolomics community to
isolate metabolites from tissues or biofluids.89–91 The most
likely to work are successive washes in solvents ranging from
the polar, such as water, to the less polar solvents such as
methanol and hexane.35 The chosen solvents would also be
very much dependent upon the type of metabolite being
isolated, for example the lipid corona will be more suited to
an isopropanol or chloroform elution92 whereas the more
polar fractions would be better suited to water and/or
methanol.35 In cases where both the polar and non-polar
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portions of the corona need to be characterized then a
biphasic extraction, such as the Bligh–Dyer,93 Folch94 and
Matyash95 methods or their derivatives, where phase
separation occurs between water and chloroform/MTBE with
polar metabolites in the aqueous phase and lipids in the
organic phase is preferred.91 These aforementioned methods
also create a protein layer either at the solvent interface or at
the bottom of the biphase, thus opening up the potential to
be able to isolate the protein, polar metabolite and apolar
metabolite portions of the complex corona. It is also likely
that varying the pH of the solvent would have a significant
effect on the elution of metabolites, either through hydrolysis
of any bonds or changing the charge status of either the
metabolite, NM or NM surface ligands thus releasing the
metabolites.88 It may also be possible to dissolve the NM if
the right pH and material is being used.96 Each NM and
surface modified NM will require optimization of the
metabolite corona isolation method, although general rules
may emerge. As such it is recommended that future studies
perform adequate method development to ensure that the
full metabolite corona is being analysed rather than a small
subset of the NM-bound metabolites. The aspects that
require significant input will be which solvents and isolation
techniques provide the most comprehensive overview of the
metabolite corona, what steps are most prone to
contamination and determination of whether any of the
metabolites are adsorbed to the reaction or incubation
vessels. A summary of these two approaches can be found in
Table 1. It is also pertinent to point out that multi-omic
sample preparation techniques are increasing in popularity
in recent years with a number of studies developing and
validating methods that isolate both the proteins and
metabolites of a given sample in similar ways as described
above.97–100 While it is likely that slight modifications may
need to be made to these approaches to ensure the NMs
themselves are also isolated to avoid injection into the
analytical platforms, this is unlikely to be a major roadblock
to the implementation to such approaches. Once the samples
are prepared it is vital that they are correctly stored in order
to prevent metabolite degradation. A general rule is to store
metabolite samples at the lowest possible temperature
available as many metabolites such as lipids degrade at room
temperature or even in a fridge.101 While many methods are
available for the analysis of metabolites in the literature it is
vital that the NM bionano interactions and corona
community follow the reporting guidelines published by the
metabolomics community102 alongside those already in place
in the NM community103–105 to ensure that high quality data
is generated and to enable the data to be re-used by
computational modelers to model the formation and
interactions of the metabolite and eventually the complete
corona.
4.2 Instrumentation for metabolomics
A wide range of analytical techniques have been
implemented in metabolomics to date, in several cases these
technologies will be new to most nanoscientists, however
some have seen extensive long-term use in several
nanoscience labs. As such, several labs already contain the
relevant instruments to characterise the metabolite corona.
Here we provide an overview of the main approaches, the
advantages and limitations of each approach, and the types
of metabolites each is optimized for (Table 2).
4.2.1 Liquid chromatography-mass spectrometry (LC-MS).
LC-MS is the most common technique applied for
metabolomics analysis106 and many reviews have discussed
the use of LC-MS for metabolomics.106–108 LC-MS has already
found use in NM metabolite corona analysis.92,96 In a typical
separation using reversed phase chemistry, polar compounds
elute first, typically with poor resolution, while more
hydrophobic compounds elute later with better
chromatographic resolution as the concentration of organic
solvent increases over the run. This reversed phase
separation is particularly suited for lipids and other non-
polar metabolites such as steroids and bile acids. In the case
of more polar metabolites such as amino acids or small
organic acids hydrophilic interaction liquid chromatography
(HILIC) is a more appropriate technique where less polar
solvents, such as methanol or acetonitrile, are used at the
start of the separation and move to the more polar water
towards the end and require the use of a different column
chemistry. The separated metabolites then enter the mass
spectrometer and are typically ionized via electrospray
ionization (ESI), which is a soft ionization technique that
produces minimal fragments. However, mass spectrometers
contain collision cells which enable the metabolites to be
fragmented. These fragmentation patterns, when combined
with accurate mass and retention order, can be used to help
annotate (putatively identify) the metabolites.109 Unlike with
the protein corona where extensive databases exist to help
identify proteins, the metabolomics community does not yet
Table 1 A comparison of passive and active isolation of the metabolite corona
Passive isolation Active isolation
Pros • Straightforward approach • Can be applied to real world applications such as NPs found in the
environment• Any biofluids can be assessed
• No recovery study required in addition to a NP
blank
• Requires few injections as a before and after analysis isn't required
• Same process for all metabolite class and NMs
Cons • Not possible to perform in real world situations • A recovery study for each material and metabolite class is required
• Requires more analyses, before and after exposure • Multiple wash steps are likely to be required to fully recover corona
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have equivalent databases, making the identification of
metabolites much more complex. However, a number of
databases are emerging such as the Human Metabolome
Database,77 Metlin110 and mycompoundID,111 which include
accurate mass measurements and fragmentation patterns.
Each database offers slightly different information as
different types of fragmentation and/or different mass
spectrometers were used, so there is still some work needed
to integrate or compare across them.
Conveniently, many nanoscientists already have access to
LC-MS, as nano liquid chromatography-mass spectrometry
(nLC-MS) is also used to characterise the protein corona.3,112
While nLC-MS is not yet widely adopted for metabolomics it
is growing in popularity31,113–117 and has proven to not only
be highly reproducible but also very sensitive.32,118–120
Indeed, this technique has already had some success with
determination of the lipid corona around nanofibrils, TiO2
and PS NMs.92
4.2.2 Gas chromatography-mass spectrometry (GC-MS).
GC-MS is a reasonably common technique in the
metabolomics fields and has been extensively described in
previous reviews.121–123 This technique is used to separate
volatilized chemicals which are resistant to thermal
degradation. These are separated using an inert carrier gas,
typically helium, which flows through a GC column.12
Analytes are retained on the GC column and are eluted by
changing the mass transfer between stationary phase and
mobile phase in a temperature dependent manner. Over the
course of the analyses the temperature increases in a similar
way to the hydrophobicity of the mobile phase in LC-MS.
Once eluted, the analytes enter a mass spectrometer that is
usually equipped with electron ionization. This is a hard
ionization technique and due to the high ionization energy
applied, 70 eV, the analytes become heavily fragmented, often
to such an extent that the parent ion is depleted.12 This high
degree of fragmentation is critical to the identification of the
analyte as each compound fragments in predictable patterns
which can be screened against a number of well-established
databases.124 To date, this approach has been used once for
the metabolite corona around 4 metal oxide NMs.88
4.2.3 Capillary electrophoresis-mass spectrometry (CE-MS).
CE is a technology that has been used in colloid, particle and
nanoscience labs for around 3 decades to characterise the
size, surface charge and zeta potential of (nano)particles and
has started to find a role in protein corona
characterisation.87,125 When coupled to a mass spectrometer
CE-MS is a valuable tool for determination and quantification
of metabolomics, offering an orthogonal separation to both
GC-MS and LC-MS.126–128 In CE separation, metabolites are
separated based upon their size and charge over a fused glass
capillary filled with a buffer solution under a high potential
difference.87 This technique is particularly suited for small
highly polar metabolites and is capable of injecting from a
very small sample volume (<5 μL) and is extensively reviewed
for metabolomics analysis.129–131 As with LC-MS, ionization is
via ESI enabling metabolite database searches to be
performed via the same (emerging) databases used for LC-MS
based metabolomics.
4.2.4 Nuclear magnetic resonance (NMR). NMR has been
used for thousands of metabolomics studies and was
initially the most widely applied technique due to its ability
to analyse complex mixtures, to quantify metabolites, to
elucidate chemical structures and the fact that it is
extremely reproducible.132,133 However, the key limitation to
Table 2 Analytical techniques for metabolite corona characterisation highlighting their advantages, disadvantages and target metabolites
Analytical technique Pros Cons Metabolites suitable for
LC-MS – hydrophilic
interaction liquid
chromatography
(HILIC) – reverse-phase
(RP)
Most popular method for
metabolomics; wide range of different
separation types possible (polar
metabolites to lipids); common in many
protein corona characterization labs
Limited databases for metabolite
identification as yet
HILIC for polar metabolites such as
amino acids, nucleotides, sugars,
neurotransmitters, environmental
contaminants
RP for apolar metabolites such as:
steroids, lipids, bile acids,
environmental contaminants
GC-MS Sensitive analysis; very reproducible;
number of databases to identify
metabolites; good for polar and volatile
metabolites
Non-volatile metabolites require
derivatisation which is time
consuming and adds expense
Volative metabolites such as amino
acids, nucleotides, PAHs,
environmental contaminants, lipids
CE-MS Highly sensitive due to low flow rates;
well suited for high polar and highly
charged metabolites can inject from
very small sample values <5 μL
Relatively expensive compared to
LC-MS and GC-MS; fewer researchers
with CE-MS experience; same limited
databases for metabolite
identification as LC-MS
Well suited for highly charged polar
metabolites such as amino acids,
nucleotides, sugars, organic acids,
neurotransmitters
DIMS (direct-infusion
mass spectrometry)
Very high throughput No definitive identification of
metabolites
There are no specific classes of
metabolites this suits, however
those present at high
concentrations are preferentially
analysed
NMR Ability to identify metabolites and their
isomers; high throughput; good
spectral databases
Poor sensitivity when compared to
mass spectrometry methods
High abundance metabolites such
as amino acids, sugars etc. however
its poor with lipids in general
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the use of NMR is a lack of sensitivity which, to some
extent, can be alleviated by larger magnetic field
instruments or use of miniaturized or cryo-probes.132 While
NMR has been used for NM characterization134 and to
identify apolipoproteins135 and conformational changes in
the proteins of the corona,136 it is still a relatively rare
technique in NM studies and has not yet been directly
applied to NM metabolite corona assessment, despite the
relative abundance of NMR instrumentation in academia
and industry. As with the other analytical techniques
discussed, NMR based metabolomics has been extensively
reviewed.121,137,138
4.3 Data analysis
Data analysis remains a bottleneck in untargeted
metabolomics analysis, particularly with ESI-MS based
techniques, due to the lack of comprehensive metabolite
databases and extensive computational requirements.139,140 A
number of open source software have been developed for
chromatogram deconvolution, metabolite annotation and
statistical analysis. These include XCMS141 and mzMine142
for deconvolution, normalization and visualization of the
datasets with annotation packages possible to linked to
them. Metaboanalyst is an online tool or can be accessed
through R which will perform data transformation,
normalization, imputation and univariate/multivariate
statistical analysis of metabolomics datasets.143 More recently
an open access end to end platform has been developed to
encompass everything from peak picking to normalization, to
missing value imputation, metabolite annotation and
statistical analysis which offers a potential solution to this
bottleneck.144 Experimental design and the research question
are vital in order to perform the correct data analysis. To
compare metabolite coronas between different NMs or
matrices a classical metabolomics study can be performed
with multivariate data analysis to highlight the metabolites
that vary significantly between coronas and matrices. The
multivariate analysis for metabolomics in these cases has
already been extensively described and reviewed.145,146
However, a study just to identify what is present in the
corona compared to a blank is more complex as missing
values skew multivariate analysis meaning a peak picking
and deconvolution step can be performed and metabolite
annotation carried out (with adequate manual confirmation
of peaks) or a known mixture of standards could be used to
form a corona, which would allow for a targeted approach to
be taken where specific masses are searched in the mass
spectra.
4.4 Untargeted analysis of the metabolite corona
NMs have already started to find a niche in assisting in
various metabolomics experiments in which they selectively
bind to metabolites and thus concentrate them facilitating
identification, as has been extensively reviewed by Zhang
Table 3 Published metabolite corona studies including inadvertent ones where the NMs were utilized to “clean up” samples to reduce interference
with target analytes
NM
Biological
matrix
NM isolation
method
Corona isolation
method
Method for
metabolite
detection Metabolites found Ref.
SWCNT Bronchoalveolar
lavage fluid
50% sucrose
gradient
Folch method LC-MS and
MALDI-MS/MS
5 PC, 4 PG, 3 PE, 2 PI, 2 PS, 1 SM 65
TiO2, PS,
CNF
Serum and
heavy cream
Centrifugation Modified Folch
method
LC-MS 6 LPC, 12 PC, 2 LPE, 6 PE, 13 DAG, 22 TAG 92
Carbonate
apatite, PS
Serum, saliva,
urine, FBS
Centrifugation CA: particle digestion
using HCl and
methanol PS: 80%
methanol
LC-MS 670 metabolites including: acyl carnitines, amino
acids, aromatic compounds, bile acids, sugars,
eicosanoids, glycerolipids, GPC, MGC, peptides,
pyridines, fatty acids, sphingolipids, steroids and
vitamins
147
CuO, ZnO Cell media and
simulated lung
fluid
Centrifugation Heating in HCl,
mercaptoethanol and
phenol
GC-MS >200 metabolites including: carboxylic acids,
primary aliphatic amines, amino acids and
derivatives, aliphatic acyclic compounds,
polyamines, phenols and derivatives and
aromatic homomonocyclic compounds
88
Anionic
and
cationic
silica
Urine N/A analysed
in situ
N/A analysed in situ NMR 1-Methylhistidine, 1-methylguanidie, betaine,
carnitine, creatinine, dimethylamine,
dimethylglycine, lysine, trigonelline,
trimethylamine N-oxide and arginine
9
Amino
modified
PS
Conditioned
Daphnia magna
culture medium
Centrifugation 2 × water wash, 1 ×
2.5 : 1 MeOH :water
Direct
infusion mass
spectrometry
102 in +ve ESI 182 in −ve ESI including: amino
acids, carbohydrates, fatty acids, glycolipids,
nucleic acids and steroids
35
CNF: cellulose nano fibril, PS: polystyrene, SWCNT: single walled carbon nanotube, PC: phosphatidylcholine, PG: phosphatidylglycerol, PE:
phosphatidylethanolamine, PI: phosphatidylinositol, PS: phosphatidylserine, SM: sphingomyelin, LPC: lysophosphatidylcholine, LPE: lyso
phosphatidylethanolamine, DAG: diacylglycerol, TAG: triacylglycerol, GPL: glycerophospholipid, MGC: mono-glycerophosphocholines, MeOH:
methanol, ESI: electrospray ionization, HCl: hydrochloric acid, MALDI-MS/MS: matrix assisted laser desorption ionization tandem mass
spectrometry.
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et al.8 Here, the use of NMs to carry out SERS, solid phase
extraction (SPE) metabolite enrichment and for enhancing
MALDI-MS ionization of metabolites are discussed in detail.
An overview of all the untargeted studies using NMs for
selective enrichment, including methods used and
metabolites identified can be found in Table 3.
4.4.1 Lipid corona. Lipids have again been a class of high
interest molecules for global analysis of NMs coronas. Initial
work exposed SWCNT to mouse lung surfactant and the lipid
corona was characterized using LC-MS, in addition to
investigating the effect of the lipid corona on SWCNT
phagocytosis by macrophages. LC-MS analysis of the corona
identified phosphatidylcholines (PC), phosphatidylglycerols
(PGs), phosphatidylinositols (PI), phosphatidylethanolamine
(PE) and a sphingomyelin in the lipid corona however, they
were found at different abundances to the lung surfactant
itself.65 This reflects a well-known characteristic of the
protein corona, that high affinity metabolites and proteins
comprise the corona rather than the high abundance ones,
however this implies that a similar evolution to the protein
corona may also apply whereby initially high abundance
lipids adsorb to be latter displaced by higher affinity lipids.
Computational modelling of the binding mechanism
suggested that the acyl chains of the phospholipids interact
via hydrogen bonding with the SWCNT, with the polar head
groups facing outwards into the biofluid (Fig. 3).65 In the
absence of PG or PS or without both PS and PG macrophage
internalization was reduced by 4, 9 and 18% respectively
indicating that not only are phospholipids important for
macrophage uptake of SWCNTs but the presence of lipid
mixtures is synergistic, suggesting that the absence of one in
the corona could prevent another from binding.65 This
highlights a significant issue with the current protein centric
view of the corona as currently the literature does not take
into account the role of metabolites in cellular uptake. The
synergistic effects seen between lipids is a particularly
interesting property and opens up the field to investigate the
possible synergistic effects of proteins and metabolites in
NM uptake and distribution.
A subsequent lipid corona investigation examined the
adsorption of lipids to cellulose nanofibrils, titania and
polystyrene NMs from serum and heavy cream to represent
exposures to humans directly via blood and food products,
respectively.92 A modified Folch method was applied to
isolate the lipid corona with good recoveries being found
across all NMs (>50%) when validated using a mixture of
lipid standards.92 The lipid coronas isolated from the two
matrices varied significantly with the serum coronas for all 3
NMs being comprised of 75% triacylglycerides (TAGs), 15–
17% phospholipids and 7.5–11% diacylglycerides (DAGs)
whereas for the heavy cream coronas for polystyrene and
cellulose nanofibrils TAGs and DAGs made up 59% and 13–
14% of the lipid corona with phospholipids accounting for a
further 25% and lysophospholipids the remaining 2–3%.
However, on titania the corona was comprised of 51% TAGs,
14% DAGs, 26% phospholipids and 9% lysophospholipids.
These differences are thought to be due to the much more
hydrophilic nature of the titania enabling up to 3 times more
lysophospholipids to adsorb.92 While no explanation was
given for these differences in TiO2 NM corona composition
between cream and blood, it is possible that
lysophospholipids are present in higher concentration in
heavy cream than in blood and out-compete the other lipids
for the hydrophilic titania NMs surface.
4.4.2 Metabolite corona. The first metabolite corona study
to use the term metabolomics was performed by Martel et al.
in 2016.147 Here the corona acquired by an endogenous
mineralo-organic NM, carbonate apatite, was investigated.
These particles were exposed to a range of biofluids including
plasma, saliva and urine all with a foetal bovine serum (FBS)
concentration of 10%. The NMs were isolated and dissolved
in acid, pelleted and dried and the metabolites solubilized
for LC-MS analysis in 80% methanol. In total, 670 potential
metabolites were uncovered from the analysis of the
metabolite corona, with 377 being putatively identified based
upon accurate mass matching with the human metabolome
database. The metabolites putatively identified spanned a
broad range of chemical classes including amino acids, bile
acids, sugars, lipids, steroids, vitamins and carnitines. There
were clear differences seen in concentrations between the
different biofluids suggesting that the metabolite corona is
biofluid dependent.147 This is a property of the metabolite
corona which reflects the behavior of the protein corona,
although it is too early days for analysis of whether trends in
metabolite and protein coronas co-vary, although our
expectation is that they will, given the multiple metabolite
protein interactions inherent in biology, and the potential
modes of complete corona formation shown in Fig. 1.
Pink et al.88 carried out extensive method development to
isolate, derivatise, separate and detect 200 metabolite
features from CuO, ZrO2, TiO2, ZnO and carbon black NMs
incubated with cell culture medium and simulated lung
fluid. Of the 200 features detected, 69% could be annotated
based upon their retention index, mass and fragmentation
patterns. Hierarchical clustering analysis (HCA) of these data
primarily clustered NMs based upon the exposure media
further strengthening the commonalities between the
metabolite and protein coronas. However, the CuO and ZnO
Fig. 3 Predicted mode of adsorption of phospholipids to the walls of
SWCNT via the acyl chains, as determined by molecular docking
simulations.65
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clustered only according to the NM composition suggesting
that the physico-chemico properties of the NM are just as
significant in corona formation as the biofluid they are exposed
too. The first principal component, of a principal component
analysis (PCA) scores plot, discriminated metabolite coronas
based upon the presence of carboxylic acid, primary aliphatic
amines, poly amines, plus other NH2 or COOH containing
metabolites. The second component separation was driven by
aromatic homo andmonocyclic compounds, phenols and their
derivatives, and pyrimidines.88 Interestingly both the Pink
et al., and Martel et al., studies demonstrated that nucleotides
adsorb into the NM corona which confirms BASI modelling
suggesting nucleotides should adsorb strongly to NMs.79 This
further raises the possibility that DNA and RNA may also bind,
thus creating a DNA/RNA corona which could be of interest for
novel biologics drugs or opening up the possibility that NMs
could potentially act as a transfer mechanism of DNA
sequences between organisms.88,147
Non-ferrous charged silica NMs were added to urine to
enhance the quality of a urine NMR metabolomics
analysis.148 The adsorption of metabolites to the anionic
NMs eliminated several overlapping peaks from cationic
metabolites including arginine which interferes with
detection of lysine, histidine and glucose. As a result, the
NMR analysis gained sensitivity, reduced peak broadening
and reduced ambiguous metabolite identification. These
anionic silica NMs were shown to have a particularly high
affinity for metabolites with multiple methyl groups
connected via a tertiary amine group such as trimethylamine
N-oxide, trigonelline and creatinine. The opposite was true
for cationic silica NMs which showed affinity for citric acid,
lactase and shikimic acid.148 These findings offer an
interesting insight into the metabolite corona, as they
demonstrate that NM surface charge is equally important for
this aspect of the corona as it is for determining the nature and
composition of the protein corona.71 Furthermore, there is no
ambiguity associated with isolating themetabolite corona from
the NMs as this study was focused upon which metabolite
signals were lost from the biofluid upon introduction of the
NMs (i.e. using the first method described in section 4.1).
4.4.3 Metabolite eco-corona. As with the protein corona, a
metabolite eco-corona can form when NMs are exposed to
environmental biofluids. This has recently been observed
with amino-modified polystyrene NMs, commonly used to
simulate microplastics or nanoscale plastic degradation
products. Here the NMs were exposed to Daphnia magna
conditioned medium to form a corona from the metabolites
excreted by the daphnids as part of their normal water
filtering activities. An extraction method comprising of 3 pure
water wash steps and a 2.5 : 1 MeOH :H2O solubilization was
assessed using SDS as a surrogate metabolite. Using a direct
infusion selected ion monitoring (SIM)-stitch mass
spectrometry approach149 a total of 284 features were
detected that spanned 6 major chemical classes including
amino acids, carbohydrates, fatty acids, glycolipids, nucleic
acids and steroids. While only a small initial probe into the
metabolite eco-corona, this offers an exciting prospect for
further evaluation of the eco-corona particularly given the
past studies investigating the role of NMs to mop up
POPs.50,51,55 This could lead to unforeseen toxicities if the
POPs form part of a dynamic corona which may then
“unload” into various organisms which are normally exposed
at lower doses based on equilibrium partitioning, or indeed
are not exposed at all to these pollutants in normal
settings.35 Importantly using a common freshwater organism
model it is possible to compliment the metabolite corona
data with the protein corona from the same organism;5,150
such studies with other model organisms may help pave the
way to uncover similarities in behavior between the two
corona classes, particularly with organisms from different
environments.
5.0 Future perspectives – metabolite
and complete NM coronas
The current knowledge on the metabolite corona supports
the notion that this is a vital area of research that is yet to be
exploited by nanoscientists for applications of NMs in the
environment, agriculture and medicine, as well as for
nanosafety assessment. It is clear that many of the NM
properties that are known to influence the composition of
the protein corona are also of significant importance to the
formation of the metabolite corona, with properties such as
NM elemental composition, surface charge, surface
modification and biological environment being highlighted
thus far.64,88,92,148 It is also becoming apparent that the NMs
concentrate the metabolites they encounter based on
preferential affinities in such a way that metabolite corona
composition does not always reflect that of the matrix.
However, there is still a long way to go to fully understand
the implications and effects of metabolite adsorption to
NMs, and especially in terms of the interactions and
cooperativity between metabolites and proteins. It will also
become increasingly important to understand the relative
contributions of proteins and metabolites to the corona, and
how each is bound and recruited into the corona (i.e. direct
interaction with the surface or via intramolecular
interactions). To begin to do this, truly quantitative methods
would be required for both the metabolite and protein
coronas beginning with more simplistic standard solutions
before progressing to the complex complete corona. These
data may then be used to develop truly representative models
of corona formation. We envision that the metabolite corona
will follow a similar path as the protein corona in terms of
interest and impact upon the nanoscience community,
whereby in less than 10 years the number of papers increased
exponentially from 35 published papers in 2009 to 234 in
2018 (PubMed “protein corona”). Factors such as NM
curvature and structure have yet to be investigated from the
metabolite perspective in addition to the time resolved
evolution of the metabolite corona. From the protein corona
we are well aware that proteins adsorb almost immediately to
Environmental Science: NanoCritical review
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
4 
Fe
br
ua
ry
 2
02
0.
 D
ow
nl
oa
de
d 
on
 3
/2
3/
20
20
 1
:5
2:
50
 P
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
Environ. Sci.: NanoThis journal is © The Royal Society of Chemistry 2020
the surface of NMs following the introduction of biological
matrices. These initial proteins are slowly exchanged for
proteins with higher affinities for the NM surface, a
significant direction for corona research would be to
investigate the time evolution of the metabolites in the
corona to inform corona kinetics models. Perhaps the most
important consideration for future research is the co-variance
of interactions between proteins and metabolites which are
yet to be investigated to understand how each influence the
other in the formation of the overall corona (Fig. 1), its
interactions with organisms and its evolution as the NMs
move through ecosystems and organisms. The combination
of the metabolite and protein corona, or the complete
corona, is likely the key to predicting NMs uptake,
localization and impacts on molecular signaling and eventual
adverse outcome pathways. It is likely also to be of vital
importance for optimization of personalized medicine.
Similarly, increased understanding of the protein and
metabolite constituents of NOM or dissolved organic matter
(DOM) is needed for characterization of environmental
coronas; NM papers using NOM or DOM to date do not
chemically characterise the NOM to identify the proteins and
metabolites present in them, focusing only the role of NOM
as a dispersant and characterising changes in NM diameter,
dissolution or zeta potential. A key recommendation for the
future is that researchers utilizing NOM/DOM provide
chemical characterization of the protein and metabolite
constituents as well as the humics.
Once the methods have been fully developed and validated
for the characterisation of the metabolite corona around all
types of NMs, we would expect that any studies which
characterise the protein corona in the future will also look
into the metabolite corona in parallel, given the similarity of
approaches utilized and their likely co-variance. Knowledge
of the complete corona will advance NMs applications in the
clinical domain and facilitate applications of NMs for
environmental remediation, as well as accelerating
understanding of the implications of both aspects of the
corona in terms of driving NM organism and cellular uptake,
distribution, toxicity, bioaccumulation and dissolution. All of
these metabolite corona data could then be used to build
models to predict metabolite corona formation and predict
its effect on biological systems in much the same way as
models have been developed for the protein corona in an
attempt to produce safe-by-design NM.6,151,152 Indeed, the
real predictive power is likely to emerge from models of the
complete corona, combining understanding of the presence
and cooperativity of binding of both metabolites and
proteins.
The ideal solution would be to characterise the protein
and metabolite coronas of the same NMs for each exposure,
as it would mean that no additional exposures would be
required and twice as much data could be collected per
sample.6 This would apply to both in vitro and in vivo studies,
and to human and environmental samples. A proposed work
flow based on current state of the art in metabolomics and
proteomics is given below (Fig. 4) for initial progress going
forward, allowing investigation of the two coronas
(metabolite and protein) in parallel until such time as a
method can be developed to isolate the protein and
metabolites corona from the same NMs in the same vial.
Among the challenges that need to be overcome in order to
Fig. 4 Proposed work flow for the parallel characterisation of metabolite and protein coronas from the same exposure media.
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do this is to develop sample preparation and isolation
methods that are compatible for both approaches; issues to
be resolved include use of additional chemicals for reduction
and alkylation of proteins that may displace metabolites in
the corona for example, whereas washing the metabolite
corona off with organic solvents may inadvertently cause a
mis-characterization of the protein corona by selectively
removing proteins such as albumin.153 Additionally, as new
sample preparation techniques and analytical platforms
develop it may become possible to simultaneously
characterize the small and large biomolecules in the
complete corona thus greatly increasing the data value from
a single analysis.100 One potential solution to this are the
biphasic extractions such as the Bligh and Dyer and the
Matyash methods previously discussed which form a bilayer
between polar and apolar metabolites but also forms a
protein layer as an interface between the solvents or as a
layer below the biphase. Once the metabolite phases have
been removed for analysis this would leave a protein layer
which could then be digested and analysed for the protein
corona. While similar approaches have been used in
proteomics and metabolomics analyses from the same
sample97–99 this would require significant work to validate to
ensure that the NMs are not mixed in with either biphase or
the protein layer. As such the Bligh and Dyer approach may
be the optimal starting point as the proteins are suspended
between the two immiscible solvents with the NMs
potentially sedimenting following the centrifugation step.
Once these methods have been developed and suitably
validated across a broad range of NMs then rapid complete
corona analysis may be possible using high throughput
methods which will enable high quality data to inform the
fields of environmental nanoscience, nanomedicine and
corona modelling.
6.0 Summary
To date, research on the metabolite corona is sparse,
focusing primarily on the lipid corona acquired by NMs
during inhalation by humans, or interactions with
xenometabolites either for remediation or to investigate
potential changes in their bioavailability through binding to
NMs. However, the studies that have been performed suggest
that there are many similarities with the well-established
protein corona in terms of specificity of binding and
evolution over time and as a result of changes in the
available biomolecules. As such, continued and increasing
research on the metabolite corona and complete corona
acquired by NMs has the potential to fill missing gaps in
understanding of bio–nano interactions and the role of the
corona and eco-corona in driving NMs interactions with
biota. As knowledge develops, future regulatory guidelines on
the use of NMs in agriculture and medicine, and broadly for
environmental risk assessment, will increasingly require
characterization of the complete corona as opposed to
focusing on the single class of biological molecules that has
dominated research to date, i.e., proteins. Metabolite corona
research offers a rich vein of information to be tapped into to
accelerate clinical and environmental applications and
regulatory oversight of NMs in the future.
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